Professor Kelly Dooley

Dr. Dooley is Professor of Medicine and the Director of the Division of Infectious Diseases at Vanderbilt University Medical Center. Her research focuses on tuberculosis therapeutics with an emphasis on clinical trials of TB drugs and HIV/TB co-treatment, as well as clinical pharmacology of TB and HIV drugs. She is lead investigator for trials of therapeutics for drug-sensitive and drug-resistant TB, TB-HIV, and pediatric TB meningitis. She is a contributor to TB trials in the AIDS Clinical Trials Group and the Tuberculosis Trials Consortium of the CDC and is a consultant to the World Health Organization on TB therapeutics and pharmacology.